Cosopt

What is it?

Composition

Cosopt combines two pressure-lowering medicines in one solution: dorzolamide hydrochloride (Dorzolamide 2%) and timolol maleate (Timolol 0.5%). You will also see the pair written as dorzolamide-timolol, or as Dorzolamide (as HCl) and Timolol (as maleate).

How to use?

Instil one drop into the affected eye twice a day, morning and evening, about 12 hours apart. Wash your hands first and avoid touching the dropper tip to the eye or any surface.

Good technique improves both effect and tolerance:

1. Tilt your head back and pull down the lower eyelid to form a small pocket.
2. Place one drop in the pocket without blinking hard.
3. Close the eye gently and press the inner corner near the nose for about 2 minutes. This keeps the drop on the eye and limits drainage into the throat.

Remove soft contact lenses before each dose and wait at least 15 minutes before putting them back. If you use more than one eye medicine, leave 5–10 minutes between products so each has time to absorb.

How does it work?

• Route: Topical ophthalmic solution (eye drops)
• Strength: dorzolamide 20 mg/mL + timolol 5 mg/mL
• Dose: instill 1 drop into the affected eye(s)
• Frequency: 2 times/day
• Timing: morning and evening, about 12 hours apart
• With meals: not related to meals
• Duration: use daily for as long as prescribed; do not stop without prescriber advice

Indications

• Open-angle glaucoma
• Ocular hypertension (IOP above target, without confirmed glaucoma damage yet)

Comparison

Cosopt is often chosen when one medicine does not bring IOP to goal or when simplifying a regimen improves adherence. The main upside is convenience: one bottle, two mechanisms. The trade-off is that fixed combinations reduce flexibility; you cannot adjust one component without changing the whole product.

When clinicians prefer alternatives:

• A prostaglandin analog is often first-line for many patients because of once-daily dosing, yet some people cannot tolerate redness or cosmetic changes.
• Timolol-containing options are often avoided in asthma, slow pulse, or certain conduction disorders.
• Carbonic anhydrase inhibitor drops can sting more on a dry ocular surface; adding lubrication can change tolerance.

Contraindications

• Hypersensitivity/allergy to dorzolamide, timolol, or any component of Cosopt
• Asthma or history of significant bronchospasm
• Severe COPD with reactive airway symptoms
• Sinus bradycardia
• Second- or third-degree AV block
• Overt cardiac failure where beta-blockers are unsuitable
• Hypersensitivity to sulfonamide-derived medicines (relevant to dorzolamide), especially if past reactions were severe

Not recommended for

Do not use Cosopt if you have had an allergic reaction to any of its ingredients, including dorzolamide or timolol.

Avoid Cosopt if you have breathing problems like asthma or severe COPD, because timolol can worsen wheeze or shortness of breath.

It may also be unsafe if you have certain heart rhythm or heart pumping problems, such as a very slow pulse or conduction issues.

Tell your clinician if you have diabetes, thyroid disease, or kidney problems, as extra monitoring or an alternative drop may be needed.

Side effects

Most side effects are local and mild, and many settle after the first days to weeks.

Common effects reported with Cosopt Eye Drops include:

• Stinging or burning right after instillation
• Bitter taste in the mouth
• Temporary blurred vision
• Redness or irritation
• Dry-eye sensation

Systemic effects are less common, yet they matter because timolol is a beta-blocker:

• Slower heart rate, dizziness, faintness
• Worsening asthma/COPD symptoms, shortness of breath, wheeze
• Fatigue or sleep disturbance in some patients

Common mistakes

Common mistakes highlighted in the article include:

• Not using tear-duct pressure (punctal occlusion), leading to bitter taste and more systemic absorption
• Missing scheduled doses, especially the evening dose
• Using drops while wearing soft contact lenses or reinserting lenses too soon after instillation
• Instilling multiple eye products too close together, increasing washout

Doctor opinions

Ophthalmologists often move to a fixed combination like dorzolamide-timolol when a single drop does not achieve a target IOP, or when a patient is realistically missing doses with a multi-bottle regimen. Fewer bottles can mean fewer missed instillations, which matters more than people expect.

A practical nuance: if the eye stings sharply for a full minute, many clinicians suspect surface dryness or sensitivity rather than “allergy,” and will add lubricating drops or consider a preservative-free option if available. The aim is adherence; uncontrolled IOP causes irreversible loss.

Frequently asked questions

How fast Cosopt lowers eye pressure

IOP reduction can begin within hours after dosing, with a more stable day-to-day effect after consistent twice-daily use. Clinicians judge success by follow-up pressure checks and optic nerve monitoring rather than symptoms, since glaucoma is often silent. The Ocular Hypertension Treatment Study reported that lowering IOP reduces the risk of developing glaucomatous damage in at-risk patients in 2002. The practical takeaway is adherence: missed doses can raise average IOP more than patients expect. ^[5]

Use with contact lenses

Soft contact lenses should be removed before instilling Cosopt. Many people wait at least 15 minutes before reinserting lenses, since drops can interact with lens material and worsen dryness or blur. If you get frequent irritation, a preservative-free approach may be discussed in clinic, since preservative sensitivity is common in long-term glaucoma care. EMA product information for dorzolamide/timolol combinations includes cautions about ocular irritation and contact lens use in 2023.

Missed dose handling

If you miss a dose, use it when you remember unless it is close to the next scheduled dose. In that case, skip the missed dose and return to your normal schedule; doubling increases overflow and systemic absorption without improving IOP control. Many ophthalmology clinics recommend linking doses to fixed routines like brushing teeth to reduce misses. WHO medication safety materials in 2022 emphasise routine-building for chronic therapies taken long-term.

Bitter taste after instillation

A bitter or metallic taste is a classic Cosopt effect and comes from drainage through the nasolacrimal duct into the throat. Punctal occlusion (pressing the inner eye corner) for 2 minutes reduces this and also lowers the chance of systemic timolol effects. EMA product information for dorzolamide/timolol combinations (2023) lists taste disturbance among the recognised, usually manageable effects, and switching studies report it as a frequent real-world complaint.

Breathing or heart symptoms

Timolol can affect the body even when used as an eye drop, since some absorption bypasses the liver’s first-pass metabolism. People with asthma, COPD, slow pulse, or conduction problems are at higher risk of wheeze, shortness of breath, dizziness, or bradycardia. MOHAP’s 2024 prescription framework supports clinician oversight for medicines where comorbidities change risk. If symptoms start after initiation, clinicians often reassess both technique (tear-duct pressure) and the choice of IOP-lowering class.

Using Cosopt with other eye drops

Cosopt can be combined with other glaucoma medicines when one product does not reach target IOP. Spacing drops by 5–10 minutes helps each medicine stay on the ocular surface long enough to absorb. Using two beta-blocker drops together is generally avoided, since it duplicates systemic beta-blockade. EMA documentation for dorzolamide/timolol combinations from 2023 addresses concomitant therapy considerations and cautions on additive effects.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.